Back to Results
First PageMeta Content
Biomarkers / Prostate-specific antigen / Urology / Prostate cancer / Prostate / Benign prostatic hyperplasia / Prostate cancer screening / 2-Amino-1-methyl-6-phenylimidazo(4 / 5-b)pyridine / PCA3 / Medicine / Tumor markers / Andrology


Mr PHIP No. 2 Interpreting the PSA test for prostate cancer Mr Phip
Add to Reading List

Document Date: 2013-05-17 07:25:32


Open Document

File Size: 56,21 KB

Share Result on Facebook

Company

P SA / New England Journal / /

Country

Australia / /

Facility

National Cancer Institute / Repatriation General Hospital / /

IndustryTerm

treatment for localised prostate cancer / treatment for prostate cancer / /

MedicalCondition

localised prostate cancer / cancers / prostate cancer If cancer / metastatic prostate cancer / BPH / cancer / disease / urinary infection / metastasis / prostate cancers / benign disease / tumour / prostatitis / particular cancer / benign prostatic hyperplasia / infection / small tumours / prostate disease / prostate cancer / inflammation / prostate and prostate cancer / prostate cancer PSA / /

MedicalTreatment

prostatectomy / radiotherapy / Hormone treatment / surgery / /

Organization

National Cancer Institute / Urology Unit / Repatriation General Hospital / /

Person

Phip Prostate / Phip Key / H. Schroder / Phip More / /

/

PublishedMedium

British Medical Journal / New England Journal of Medicine / British Journal of Urology / Journal of Clinical Oncology / /

RadioStation

Cronin AM / /

Region

New England / /

Technology

cancer detection / /

URL

www.prostatehealth.org.au / www.prostate.org.au / www.andrologyaustralia.org.au / /

SocialTag